iothalamate-meglumine and Vomiting

Topics: Acute Disease; Contrast Media; Headache; Humans; Iothalamate Meglumine; Meningitis; Nausea; Solubility; Vomiting; Water

In a comparative study between Dimer X and Amipaque (metrizamide) for lumbar myelography it was found that there is a little higher frequency of monor, but unimportant side effects after Amipaque. Amipaque has also been used for thoracocervical myelography with excellent results and without greater discomfort than after myelography in the lumbar region. A new puncture technique was used for the eximation of the cervical region alone: lateral puncture on the neck between the laminae of C1 and C2 under TV control. In more than 75 reinvestigations no arachnoid changes were observed.

Topics: Adult; Aged; Female; Fever; Headache; Humans; Iodobenzoates; Iothalamate Meglumine; Iothalamic Acid; Lumbosacral Region; Male; Metrizamide; Middle Aged; Myelography; Nausea; Neck; Seizures; Subarachnoid Space; Surveys and Questionnaires; Urination Disorders; Vomiting

Topics: Cerebral Ventriculography; Contrast Media; Drug Tolerance; Electroencephalography; Electromyography; Headache; Humans; Iodobenzoates; Iothalamate Meglumine; Metrizamide; Myelography; Nausea; Vomiting

Topics: Adolescent; Angiocardiography; Arrhythmias, Cardiac; Bronchial Spasm; Cardiac Catheterization; Child; Contrast Media; Cough; Dyspnea; Geriatrics; Headache; Heart Defects, Congenital; Humans; Hypotension; Infant; Infant, Newborn; Iothalamate Meglumine; Iothalamic Acid; Mortality; Pulmonary Edema; Taste; Toxicology; Urticaria; Vomiting